|
- 2019
Phase II study of chemoradiotherapy combined with gemcitabine plus nab-paclitaxel for unresectable locally advanced pancreatic ductal adenocarcinoma (NUPAT 05 Trial): study protocol for a single arm phase II studyKeywords: II study, Gemcitabine, nab-paclitaxel, chemoradiation, unresectable locally advanced pancreatic cancer Abstract:
|